{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,4]],"date-time":"2024-02-04T00:12:36Z","timestamp":1707005556358},"reference-count":11,"publisher":"Japanese Society of Internal Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2024,2,1]]},"DOI":"10.2169\/internalmedicine.1871-23","type":"journal-article","created":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T22:12:42Z","timestamp":1687299162000},"page":"439-442","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of Bisphosphonate for Urolithiasis Complicated by Osteogenesis Imperfecta"],"prefix":"10.2169","volume":"63","author":[{"given":"Ryusuke","family":"Deguchi","sequence":"first","affiliation":[{"name":"Department of Urology, Wakayama Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Kohjimoto","sequence":"additional","affiliation":[{"name":"Department of Urology, Wakayama Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohei","family":"Maruyama","sequence":"additional","affiliation":[{"name":"Department of Urology, Wakayama Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuya","family":"Iwahashi","sequence":"additional","affiliation":[{"name":"Department of Urology, Wakayama Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Muraoka","sequence":"additional","affiliation":[{"name":"Department of Urology, Wakayama Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahito","family":"Wakamiya","sequence":"additional","affiliation":[{"name":"Department of Urology, Wakayama Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shimpei","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Urology, Wakayama Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Hara","sequence":"additional","affiliation":[{"name":"Department of Urology, Wakayama Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Bacon S, Crowley R. Developments in rare bone diseases and mineral disorders. Ther Adv Chronic Dis 9: 51-60, 2018.","DOI":"10.1177\/2040622317739538"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Sillence DO, Rimoin DL. Classification of osteogenesis imperfect. Lancet 1: 1041-1042, 1978.","DOI":"10.1016\/S0140-6736(78)90763-8"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Wang H, Huang X, Wu A, Li Q. Management of anesthesia in a patient with osteogenesis imperfecta and multiple fractures: a case report and review of the literature. J Int Med Res 49: 3000605211028420, 2021.","DOI":"10.1177\/03000605211028420"},{"key":"4","unstructured":"4. Venugopala D, Babu S, Korath MP, Jagadeesan K. Renal stone disease as extra skeletal manifestation of osteogenesis imperfecta. J Assoc Physicians India 48: 1027-1028, 2000."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Qadar LT, Ochani RK, Shaikh A, Arsalan Q, Ali R. A unique association of osteogenesis imperfecta with bilateral renal osteodystrophy and gastroenteritis in a three-year-old boy. Cureus 11: e4467, 2019.","DOI":"10.7759\/cureus.4467"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Vetter U, Maierhofer B, M\u00fcller M, et al. Osteogenesis imperfecta in childhood: cardiac and renal manifestations. Eur J Pediatr 149: 184-187, 1989.","DOI":"10.1007\/BF01958277"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Chines A, Petersen DJ, Schranck FW, Whyte MP. Hypercalciuria in children severely affected with osteogenesis imperfecta. J Pediatr 119: 51-57, 1991.","DOI":"10.1016\/S0022-3476(05)81038-8"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Yasui T, Itoh Y, Okada A, et al. Alendronate reduces the excretion of risk factors for calcium phosphate stone formation in postmenopausal women with osteoporosis. Urol Int 83: 226-229, 2009.","DOI":"10.1159\/000230029"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Prochaska M. Bisphosphonates and management of kidney stones and bone disease. Curr Opin Nephrol Hypertens 30: 184-189, 2021.","DOI":"10.1097\/MNH.0000000000000682"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Barcelo P, Wuhl O, Servitge E, Rousaud A, Pak CY. Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol 150: 1761-1764, 1993.","DOI":"10.1016\/S0022-5347(17)35888-3"},{"key":"11","unstructured":"11. Tiselius HG, Berg C, Fornander AM, Nilsson MA. Effects of citrate on the different phases of calcium oxalate crystallization. Scanning Microsc 7: 381-389; discussion 389-390, 1993."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/3\/63_1871-23\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,3]],"date-time":"2024-02-03T03:33:13Z","timestamp":1706931193000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/3\/63_1871-23\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,1]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.1871-23","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,1]]},"article-number":"1871-23"}}